Improving screening for hepatocellular carcinoma by incorporating data on levels of α-fetoprotein, over time.
about
Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysisControversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinomaClinical applications of squamous cell carcinoma antigen-immunoglobulins M to monitor chronic hepatitis CScreening and surveillance for hepatocellular carcinoma: perspective of a new era?Liver masses: a clinical, radiologic, and pathologic perspective.A new approach to the use of α-fetoprotein as surveillance test for hepatocellular carcinoma in patients with cirrhosis.Screening for hepatocellular carcinoma and cholangiocarcinoma: Can biomarkers replace imaging?Alpha-Fetoprotein Detection of Hepatocellular Carcinoma Leads to a Standardized Analysis of Dynamic AFP to Improve Screening Based Detection.Machine learning algorithms outperform conventional regression models in predicting development of hepatocellular carcinomaHepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice.Development and Internal Validation of a Model for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis.The changing landscape of hepatocellular carcinoma: etiology, genetics, and therapyFactors that affect accuracy of α-fetoprotein test in detection of hepatocellular carcinoma in patients with cirrhosis.Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implicationsA new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis C and cirrhosis.Update on biomarkers of hepatocellular carcinoma.Improved Detection of Hepatocellular Carcinoma by Using a Longitudinal Alpha-Fetoprotein Screening Algorithm.Biomarkers for the early diagnosis of bacterial infection and the surveillance of hepatocellular carcinoma in cirrhosis.A Bayesian screening approach for hepatocellular carcinoma using multiple longitudinal biomarkers.Improved Performance of Serum Alpha-Fetoprotein for Hepatocellular Carcinoma Diagnosis in HCV Cirrhosis with Normal Alanine Transaminase.Stemness-related transcriptional factors and homing gene expression profiles in hepatic differentiation and cancer.Diagnostic delays are common among patients with hepatocellular carcinoma.Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: implications for its clinical use.On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir.The prognostic correlation of AFP level at diagnosis with pathological grade, progression, and survival of patients with hepatocellular carcinoma.Evaluation methods for pretransplant oncologic markers and their prognostic impacts in patient undergoing living donor liver transplantation for hepatocellular carcinoma.Evaluating screening approaches for hepatocellular carcinoma in a cohort of HCV related cirrhosis patients from the Veteran’s Affairs Health Care System.Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis.Should AFP (or any biomarkers) be used for HCC surveillance?Applying reinforcement learning techniques to detect hepatocellular carcinoma under limited screening capacity.The Evolution of the Use of Serum Alpha-fetoprotein in Clinical Liver Cancer SurveillanceSperm-Associated Antigen 5 Expression Is Increased in Hepatocellular Carcinoma and Indicates Poor Prognosis
P2860
Q21144594-C5895BCF-A447-432D-9AD6-2C6BC105132FQ26772324-B76879E3-4B0E-4E35-AA1E-D8E6E2F78F69Q26774517-E82BD230-F053-4D82-9D13-C221454E233CQ30244651-549CE11D-D1E7-4DE1-9795-346BE4C72281Q30403670-C83D3D6A-70B0-49F5-AEE9-0025F799A51CQ35677687-1BE64C24-D6CB-43C9-987D-26202159B579Q36000994-29556826-F759-4605-9179-79A3C5154BC5Q36053838-72347E76-5C6D-4D79-A3BF-6886BBC4841EQ36175747-324B13F5-4720-4CC1-9183-F60AAD782F50Q36199751-23713EDA-5091-432E-8E03-E236EA08C287Q36404471-341BB7F6-2A70-4DFD-B037-FE3213BC37C6Q37606028-8D872909-4193-4BE9-9A0D-F54BCC1E00D5Q37684651-F3AEFC8F-8DA6-470D-AD81-964055040AF9Q37706763-DBDD3B85-5BA2-4238-89AE-D6D4EF14181EQ37710955-BF151367-6CCC-41EE-92D3-900AFA3EA332Q38166133-1F8B912D-415F-4053-8303-5D54387A254BQ38279464-2076A6F8-5A18-439F-BD94-04F24B2F7452Q38637305-59373397-5509-486C-A767-3C6C743FE636Q38686490-FE96C625-61C1-4AB3-ABA2-3B3F1444E847Q38930591-4B60728A-3721-40A2-87F9-CB81C1D0C7B2Q39395370-EDF3936C-EDC0-4EA0-A455-F061AC139CAEQ40279432-8B3B2210-060B-46DE-8ED0-E62EE85C1F2CQ42225289-21BAEBC6-F3DD-4D0B-92B1-53969DB16552Q42262667-D21004B0-18D6-4375-860F-6FF5499AC717Q42373936-8E4230F8-0D8F-4357-AE2C-3D086EEBF261Q43714851-8D94FA31-583C-4CE8-95B9-419FEF97DEB7Q47120096-0612BD35-361C-4B3F-B24F-25E0A3330BCEQ50095994-D1B96007-0F4D-47C9-B7D7-646548406EA1Q50223186-4FC8C543-42A1-4381-9126-12756E568149Q50629271-57B7CCBA-94A4-43DC-A5B7-A11331D7D98DQ58457880-68079C29-6B0A-4654-B037-79AD07B44281Q58693733-FA29C55C-8907-42B6-BF2E-72071D498CFC
P2860
Improving screening for hepatocellular carcinoma by incorporating data on levels of α-fetoprotein, over time.
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Improving screening for hepato ...... s of α-fetoprotein, over time.
@ast
Improving screening for hepato ...... s of α-fetoprotein, over time.
@en
type
label
Improving screening for hepato ...... s of α-fetoprotein, over time.
@ast
Improving screening for hepato ...... s of α-fetoprotein, over time.
@en
prefLabel
Improving screening for hepato ...... s of α-fetoprotein, over time.
@ast
Improving screening for hepato ...... s of α-fetoprotein, over time.
@en
P2093
P1476
Improving screening for hepato ...... s of α-fetoprotein, over time.
@en
P2093
Amit G Singal
Elliot Lee
Mariel S Lavieri
Michael Volk
Selwan Edward
P304
P356
10.1016/J.CGH.2012.11.029
P407
P577
2012-12-12T00:00:00Z